Aptus Capital Advisors »

Xilio Therapeutics shares owned by Aptus Capital Advisors

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Aptus Capital Advisors from 13F filings

Historical chart of Aptus Capital Advisors investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Aptus Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Aptus Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $21k 25k 0.84
2025-06-30 $17k 25k 0.68
2025-03-31 $33k 46k 0.72
2024-12-31 $39k 41k 0.96

More positions owned by Aptus Capital Advisors

Ishares Tr Iboxx Hi Yd Etf (HYG)
Etf Ser Solutions Aptus Collrd Inv (ACIO)
Doordash Cl A (DASH)
Etf Ser Solutions Aptus Defined (DRSK)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
Microsoft Corporation Put Option (MSFT)
salesforce (CRM)
Tesla Motors (TSLA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Eli Lilly & Co. (LLY)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Exch Trd Slf Idx Bulletshs 2032 (BSCW)

View all positions for Aptus Capital Advisors

Top funds holding Xilio Therapeutics

Gilead Sciences
Bain Capital Life Sciences Investors
Merck & Co
Takeda Pharmaceutical
Morgan Stanley
Vanguard Group
AJU IB Investment
FMR
Geode Capital Management
Squarepoint Ops
Trustees of Columbia University in the City of New York
Renaissance Technologies
Balyasny Asset Management
State Street Corporation
Two Sigma Investments

View all funds holding Xilio Therapeutics